Crossmark

SER recommendations on treatment of refractory Behçet's syndrome

Published Print: 2024-04

Authors

Moriano Morales, Clara

Graña Gil, Jenaro

Brito García, Noé

Martín Varillas, José Luis

Calvo del Río, Vanesa

Moya Alvarado, Patricia

Narváez García, Francisco Javier

Espinosa, Gerard

Díaz del Campo Fontecha, Petra

Guerra Rodríguez, Mercedes

Mateo Arranz, José

López Gómez, Manuela

Francisco Hernández, Félix Manuel

Trujillo, M. Mar

dos Santos Sobrín, Raquel

Martín Sánchez, Juan Ignacio

Maese Manzano, Jesús

Suárez Cuba, Julio
Funding

Funding for this research was provided by:

Eli Lilly and Company

Pfizer
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01
More Information

This article is maintained by: Elsevier

Article Title: SER recommendations on treatment of refractory Behçet's syndrome

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2023.12.006

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2023.12.001

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current